Related references
Note: Only part of the references are listed.Unique transcriptional profile of liver-resident memory CD8+ T cells induced by immunization with malaria sporozoites
S-W Tse et al.
GENES AND IMMUNITY (2013)
Comparative Analysis of the Magnitude, Quality, Phenotype, and Protective Capacity of Simian Immunodeficiency Virus Gag-Specific CD8+ T Cells following Human-, Simian-, and Chimpanzee-Derived Recombinant Adenoviral Vector Immunization
Kylie M. Quinn et al.
JOURNAL OF IMMUNOLOGY (2013)
Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
Pablo Penaloza-MacMaster et al.
JOURNAL OF VIROLOGY (2013)
Comparative Analysis of Simian Immunodeficiency Virus Gag-Specific Effector and Memory CD8+ T Cells Induced by Different Adenovirus Vectors
Wendy G. Tan et al.
JOURNAL OF VIROLOGY (2013)
Qualitative and Quantitative Analysis of Adenovirus Type 5 Vector-Induced Memory CD8 T Cells: Not as Bad as Their Reputation
Maria Abildgaard Steffensen et al.
JOURNAL OF VIROLOGY (2013)
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP)
Martha Sedegah et al.
MALARIA JOURNAL (2013)
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in Healthy Gambian and Kenyan Adults
Caroline Ogwang et al.
PLOS ONE (2013)
Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine
Robert A. Seder et al.
SCIENCE (2013)
Human adenovirus 5-vectored Plasmodium falciparum NMRC-M3V-Ad-PfCA vaccine encoding CSP and AMA1 is safe, well-tolerated and immunogenic but does not protect against controlled human malaria infection
Cindy Tamminga et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Global malaria mortality between 1980 and 2010: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2012)
Phase Ia Clinical Evaluation of the Safety and Immunogenicity of the Plasmodium falciparum Blood-Stage Antigen AMA1 in ChAd63 and MVA Vaccine Vectors
Susanne H. Sheehy et al.
PLOS ONE (2012)
Protective CD8+T lymphocytes in Primates Immunized with Malaria Sporozoites
Walter R. Weiss et al.
PLOS ONE (2012)
Relevance of long-lived CD8(+) T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination
Jose R. Vasconcelos et al.
FRONTIERS IN IMMUNOLOGY (2012)
Memory CD8T cells specifc for Plasmodia liver-stage antigens maintain protracted protection against malaria
Urszula Krzych et al.
FRONTIERS IN IMMUNOLOGY (2012)
Superior Antimalarial Immunity after Vaccination with Late Liver Stage-Arresting Genetically Attenuated Parasites
Noah S. Butler et al.
CELL HOST & MICROBE (2011)
Long-Term Humoral and Cellular Immune Responses Elicited by a Heterologous Plasmodium vivax Apical Membrane Antigen 1 Protein Prime/Adenovirus Boost Immunization Protocol
Leoneide Erica Maduro Bouillet et al.
INFECTION AND IMMUNITY (2011)
CD8+ T Effector Memory Cells Protect against Liver-Stage Malaria
Arturo Reyes-Sandoval et al.
JOURNAL OF IMMUNOLOGY (2011)
HIV-DNA Priming Alters T Cell Responses to HIV-Adenovirus Vaccine Even When Responses to DNA Are Undetectable
Stephen C. De Rosa et al.
JOURNAL OF IMMUNOLOGY (2011)
Protective HIV-specific CD8+ T cells evade Treg cell suppression
Shokrollah Elahi et al.
NATURE MEDICINE (2011)
Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells
Joanne M. Lumsden et al.
PLOS ONE (2011)
Adenovirus 5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part A: Safety and Immunogenicity in Seronegative Adults
Martha Sedegah et al.
PLOS ONE (2011)
Adenovirus-5-Vectored P. falciparum Vaccine Expressing CSP and AMA1. Part B: Safety, Immunogenicity and Protective Efficacy of the CSP Component
Cindy Tamminga et al.
PLOS ONE (2011)
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
David W. Porter et al.
VACCINE (2011)
Prime-Boost Immunization with Adenoviral and Modified Vaccinia Virus Ankara Vectors Enhances the Durability and Polyfunctionality of Protective Malaria CD8(+) T-Cell Responses
Arturo Reyes-Sandoval et al.
INFECTION AND IMMUNITY (2010)
Malaria elimination: worthy, challenging, and just possible
Pam Das et al.
LANCET (2010)
Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein
Martha Sedegah et al.
MALARIA JOURNAL (2010)
Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults
Clayton D. Harro et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming
Stephen M. Todryk et al.
IMMUNOLOGY (2009)
Sterile Protection against Plasmodium knowlesi in Rhesus Monkeys from a Malaria Vaccine: Comparison of Heterologous Prime Boost Strategies
George Jiang et al.
PLOS ONE (2009)
Plasmodium falciparum apical membrane antigen 1 vaccine elicits multifunctional CD4 cytokine-producing and memory T cells
Maria Cecilia Huaman et al.
VACCINE (2009)
Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers
Claus Lundegaard et al.
BIOINFORMATICS (2008)
HLA class I supertypes: a revised and updated classification
John Sidney et al.
BMC IMMUNOLOGY (2008)
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults
Frances H. Priddy et al.
CLINICAL INFECTIOUS DISEASES (2008)
Protective CD8(+) T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response
Michael Glen Overstreet et al.
IMMUNOLOGICAL REVIEWS (2008)
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria
Nathan W. Schmidt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Apical membrane antigen 1: a malaria vaccine candidate in review
Edmond J. Remarque et al.
TRENDS IN PARASITOLOGY (2008)
Memory CD8(+) T cell responses expand when antigen presentation overcomes T cell self-regulation
Ian A. Cockburn et al.
JOURNAL OF IMMUNOLOGY (2008)
T-cell quality in memory and protection: implications for vaccine design
Robert A. Seder et al.
NATURE REVIEWS IMMUNOLOGY (2008)
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naive adults
Kent E. Kester et al.
VACCINE (2007)
A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge
S. J. Dunachie et al.
INFECTION AND IMMUNITY (2006)
Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines
Jun Miao et al.
VACCINE (2006)
Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study
S-H Yang et al.
GENE THERAPY (2006)
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area
P Bejon et al.
VACCINE (2006)
Immune response to pre-erythrocytic stages of malaria parasites
DL Doolan et al.
CURRENT MOLECULAR MEDICINE (2006)
Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara
DP Webster et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers
JM Vuola et al.
JOURNAL OF IMMUNOLOGY (2005)
A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites
O Silvie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malaria
SD Polley et al.
VACCINE (2004)
A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults
VS Moorthy et al.
PLOS MEDICINE (2004)
DNA vaccination: the answer to stable, protective T-cell memory?
JR Kirman et al.
CURRENT OPINION IN IMMUNOLOGY (2003)
Early self-regulatory mechanisms control the magnitude of CD8+ T cell responses against liver stages of murine malaria
JCR Hafalla et al.
JOURNAL OF IMMUNOLOGY (2003)
Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes
SC Gilbert et al.
VACCINE (2002)
Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine
RB Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
